Webinar: Egypt's New eCTD Framework | EXTEDO
October 1, 2026 11:00 CEST |  12:00 Cairo Time

Webinar: Egypt's New eCTD Framework

The publication of the eCTD Module 1 Specifications and Validation Criteria represents a major milestone for the Egyptian Drug Authority (EDA) on its path to digital transformation. To mark this occasion, our valued partner in Egypt, DAF- Digital Access to Finance, with whom we have the honor of accompanying the EDA, has organized an exceptional webinar series that thoroughly examines this latest development.  

In three webinars, experienced professionals will discuss the various aspects of the latest updates. They will cover Egypt’s new digital regulatory requirements, the eCTD process, as well as submissions, validation, document management, and innovative pharmacometrics.

In the first of three sessions, we discover together how Egypt’s regulatory landscape is evolving and gain valuable insights into the new EDA eCTD framework, including Module 1 requirements, specifications, and validation criteria. Join us to understand the differences between eCTD 3.2 and v4 and learn how to prepare your organization for a smooth and compliant transition.

Date: 01 October 2026 
Time: 12:00 PM to 2:00 PM Cairo Time (GMT+3) ι  11:00 AM to 1:00 PM CEST

Registration: https://events.teams.microsoft.com/event/a27744eb-81c7-4953-84c3-f979f8feb8d1@9b0bcdeb-6e81-4474-b1f9-fa227c7b140a?source=copyLinkOneEventsShareDialog

Participation is free of charge. 

Please note that a large part of the webinar will be conducted in Arabic. 


Topics include:

  • Egypt's Digital Transformation in Regulatory Affairs 
  • The Future of Regulatory Science: Differentiation Between eCTD v3.2 and eCTD v4.0
  • Organizational Readiness for CTD/eCTD

Register now for the next session to get the full experience: Webinar: Building a Compliant eCTD Submission | EXTEDO 

 

If you would like to learn more about how DAF and EXTEDO contribute to bringing the EDA's vision to life, have a look at our blog post: Egyptian Drug Authority and EXTEDO Launch Phase II of Egypt’s Pharmaceutical Digital Transformation | EXTEDO 

 

Ayman El Bishbishi-DAF



Dr. Ayman El Bishbishi 
Digital Sales Manager
DAF for Digital Solutions

 

 
Amr Adel_DAF Dr. Amr Adel
Regulatory Affairs Training Lead
DAF for Digital Solutions
Frank Frank Dickert
Senior Business Consultant 
EXTEDO